Literature DB >> 17718543

Zinc lowers amyloid-beta toxicity by selectively precipitating aggregation intermediates.

K Garai1, B Sahoo, S K Kaushalya, R Desai, S Maiti.   

Abstract

Soluble amyloid-beta (Abeta) aggregates are suspected to play a major role in Alzheimer's disease. Zn2+ at a concentration of a few micromolar, which is too dilute to affect the precipitation equilibrium of Abeta, can destabilize these aggregates [Garai, K., Sengupta, P., Sahoo, B., and Maiti, S. (2006) Biochem. Biophys. Res. Commun. 345, 210-215]. Here we investigate the nature of these aggregates in the context of the precipitation pathway, the mechanism underlying their destabilization, and the biological consequences of this destabilization. We show that the larger soluble aggregates (size >10 nm) form only in supersaturated Abeta solutions, implying that they are intermediates in the pathway toward fibril formation. We also show that Zn2+ destabilizes these intermediates by accelerating their aggregation kinetics. The resulting change in the size distribution of the Abeta solution is sufficient to eliminate its toxicity to cultured mammalian neurons. Our results provide an explanation for the existing observations that Zn2+ at a concentration of a few micromolar significantly reduces Abeta toxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17718543     DOI: 10.1021/bi700798b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  41 in total

1.  Probing the efficacy of peptide-based inhibitors against acid- and zinc-promoted oligomerization of amyloid-β peptide via single-oligomer spectroscopy.

Authors:  Lyndsey R Powell; Kyle D Dukes; Robin K Lammi
Journal:  Biophys Chem       Date:  2011-09-08       Impact factor: 2.352

2.  Measurement of the attachment and assembly of small amyloid-β oligomers on live cell membranes at physiological concentrations using single-molecule tools.

Authors:  Suman Nag; Jiji Chen; J Irudayaraj; S Maiti
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

Review 3.  Metals, oxidative stress and neurodegenerative disorders.

Authors:  Klaudia Jomova; Dagmar Vondrakova; Michael Lawson; Marian Valko
Journal:  Mol Cell Biochem       Date:  2010-08-22       Impact factor: 3.396

4.  Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-06       Impact factor: 11.205

5.  Protective spin-labeled fluorenes maintain amyloid beta peptide in small oligomers and limit transitions in secondary structure.

Authors:  Robin Altman; Sonny Ly; Silvia Hilt; Jitka Petrlova; Izumi Maezawa; Tamás Kálai; Kálmán Hideg; Lee-Way Jin; Ted A Laurence; John C Voss
Journal:  Biochim Biophys Acta       Date:  2015-09-14

6.  The effect of Cu(2+) and Zn(2+) on the Aβ42 peptide aggregation and cellular toxicity.

Authors:  Anuj K Sharma; Stephanie T Pavlova; Jaekwang Kim; Jungsu Kim; Liviu M Mirica
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

7.  Substantial contribution of the two imidazole rings of the His13-His14 dyad to Cu(II) binding in amyloid-β(1-16) at physiological pH and its significance.

Authors:  Byong-kyu Shin; Sunil Saxena
Journal:  J Phys Chem A       Date:  2011-04-14       Impact factor: 2.781

8.  On the stability of the soluble amyloid aggregates.

Authors:  Bankanidhi Sahoo; Suman Nag; Parijat Sengupta; Sudipta Maiti
Journal:  Biophys J       Date:  2009-09-02       Impact factor: 4.033

9.  Effect of zinc binding on β-amyloid structure and dynamics: implications for Aβ aggregation.

Authors:  Nasrollah Rezaei-Ghaleh; Karin Giller; Stefan Becker; Markus Zweckstetter
Journal:  Biophys J       Date:  2011-09-07       Impact factor: 4.033

Review 10.  Extracellular Zn2+-Dependent Amyloid-β1-42 Neurotoxicity in Alzheimer's Disease Pathogenesis.

Authors:  Yuichi Sato; Mako Takiguchi; Haruna Tamano; Atsushi Takeda
Journal:  Biol Trace Elem Res       Date:  2020-04-13       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.